Holen Sie sich die Stockscreener-App
1.47
2.08%
0.03
Handel nachbörslich:
1.47
Boundless Bio Inc Aktie (BOLD) Neueste Nachrichten
TradingKey - TradingKey
Number of shareholders of Boundless Bio, Inc. – NASDAQ:BOLD - TradingView
BOLD: ecDNA-targeted therapies offer a novel approach for hard-to-treat oncogene amplified cancers - TradingView
Boundless Bio Releases Q1 2026 Financial Results - AlphaStreet
Boundless Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Boundless Bio, Inc. 1Q 2026: Net income $(13.6)M, EPS $(0.60) — 10-Q Summary - TradingView
Boundless Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Boundless Bio (NASDAQ: BOLD) trims spend, ends HQ lease, guides cash into 2H 2028 - Stock Titan
Boundless Bio (Nasdaq: BOLD) Q1 2026 results and $92.8M cash runway - Stock Titan
Boundless Bio 1Q Loss/Shr 60c >BOLD - Moomoo
Cancer drug trial keeps enrolling as Boundless Bio says cash lasts to 2028 - Stock Titan
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights - Taiwan News
What BoundlessBio (BOLD) is doing that smart investors recognize (Breakout Watch) 2026-05-06Crowd Sentiment Stocks - newser.com
Boundless Bio Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
[ARS] Boundless Bio, Inc. SEC Filing - Stock Titan
Boundless Bio (NASDAQ: BOLD) details 2026 virtual meeting and pay - Stock Titan
BOLD | Boundless Bio, Inc. Common Insider Trading - Quiver Quantitative
BOLD (Boundless Bio Inc.) falls 3.07% following wider-than-expected Q4 2025 earnings per share miss.Days To Cover - Xã Thanh Hà
OGI (Organigram Global Inc. Common Shares) delivers blowout Q1 2026 results with 62 percent annual revenue growth and positive earnings.Dividend Safety - Cổng thông tin điện tử tỉnh Lào Cai
BoundlessBio (BOLD) Stock: Technical Trend Review | Boundless Bio Inc. misses EPS estimates by 9.4% on wider lossesPEG Ratio - Cổng thông tin điện tử tỉnh Lào Cai
BoundlessBio (BOLD) Stock Top Holdings (-0.32%) 2026-04-20Hot Community Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Brickell Biotech Inc (BBI) - Minichart
BoundlessBio (BOLD) Stock: Mid-Year Review (-3.07%) 2026-04-18Community Chart Signals - UBND thành phố Hải Phòng
Is Titan Machinery (TITN) stock cheap relative to fundamentals (+4.84%) 2026-04-18Verified Stock Signals - Cổng thông tin điện tử tỉnh Lào Cai
Boundless Bio Presents Preclinical Data on BBI-940, a Novel Kinesin Degrader, at AACR Annual Meeting 2026 - Quiver Quantitative
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting - GlobeNewswire Inc.
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Tuesday's session: gap up and gap down stocks - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market SessionAvanos Medical (NYSE:AVNS), Boundless Bio - Benzinga
Boundless Bio, Inc. Files Form 8-K with SEC – Corporate Details, Nasdaq Listing, and Emerging Growth Company Status - Minichart
Boundless Bio to terminate San Diego lease, agrees to $10 million payment - Investing.com Australia
Boundless Bio Terminates Major Long-Term San Diego Lease - TipRanks
Boundless Bio (NASDAQ: BOLD) pays $10M to exit long-term lab lease - Stock Titan
Chipmakers Recap: Is Boundless Bio Inc in a long term uptrend2026 Buyback Activity & Consistent Income Trade Ideas - baoquankhu1.vn
GODN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
EPS Watch: Is Boundless Bio Inc subject to activist investor interest2026 Volume Leaders & Safe Entry Point Alerts - baoquankhu1.vn
Aug Decliners: What hedge funds are buying Akanda Corp2026 Price Targets & Weekly High Potential Stock Alerts - baoquankhu1.vn
PMN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Swing Trade: Is EFOI forming higher highs and higher lows2026 Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
JSPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Is BoundlessBio (BOLD) Stock Leading the Market | Price at $1.09, Up 1.39%Parabolic SAR - Newser
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
BOLD PE Ratio & Valuation, Is BOLD Overvalued - Intellectia AI
CUE.O PE Ratio & Valuation, Is CUE.O Overvalued - Intellectia AI
LIXT PE Ratio & Valuation, Is LIXT Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
APUS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Volume Recap: Will Boundless Bio Inc face regulatory challenges2026 WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
If You Invested $1,000 in Neuphoria Therapeutics Inc (NEUP) - Stock Titan
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
What analysts say about Boundless Bio Inc stockPortfolio Gains Report & Reliable Intraday Trade Plans - baoquankhu1.vn
Checkpoint Inhibitors Competitive Landscape & Pipeline 2026: Emerging Therapies, ROA, Molecules, Companies and Future Outlook - Barchart
Checkpoint Inhibitors Competitive Landscape & Pipeline 2026: - openPR.com
Stop Loss: Can Boundless Bio Inc ride the EV wave2026 Gainers & Long Hold Capital Preservation Plans - baoquankhu1.vn
If You Invested $1,000 in Rallybio Corp (RLYB) - Stock Titan
If You Invested $1,000 in SeaStar Medical Holding Corp (ICU) - Stock Titan
BOLD Technical Analysis & Stock Price Forecast - Intellectia AI
MRKR PE Ratio & Valuation, Is MRKR Overvalued - Intellectia AI
Boundless Bio: Underestimated Biotech With First-In-Class EcDNA Targeted Kinesin Degrader - Seeking Alpha
Risks Report: Is Boundless Bio Inc stock a smart retirement pick2026 Price Momentum & Technical Confirmation Trade Alerts - baoquankhu1.vn
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026 - The Manila Times
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):